R&D Pipeline

Lysigen R&D Pipeline

We are focused on topical bacterial infection since the size of the market is large and there are virtually no totally effective and affordable solutions. Over time, we will look to in-license other later stage biological dermatological treatments.

Phagelux R&D Pipeline